Bone morphogenetic protein 4 (BMP4), a growth factor with anti-proliferative properties, has been proposed as a therapeutic option for GBM since it downregulates stemness markers like SOX2, inhibits tumor growth, and induces (reversible) astrocytic differentiation [8,9,10,11]. Here, BMP4 is linked to glioblastoma.